lysine has been researched along with Muscular Weakness in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, P; Bautmans, I; Buyl, R; Gorus, E; Njemini, R; Pool-Goudzwaard, A; Vantieghem, S | 1 |
Beck, J; Dalal, M; Ferrucci, L; Fried, LP; Semba, RD; Sun, K | 1 |
Batish, SD; Biesecker, LG; Blouin, R; Brandt, C; Coppola, G; Ferguson, CJ; Grant, AE; Hoffman, S; Lenk, GM; Meisler, MH; Nicholson, G; Reddel, SW; Scheuerle, A; Simpson, E; Towne, CF; Yasick, M | 1 |
Schröder, JM; Sindern, E; Vorgerd, M; Züchner, S | 1 |
Chen, HI; Hsu, BG; Hsu, YH | 1 |
5 other study(ies) available for lysine and Muscular Weakness
Article | Year |
---|---|
Reaction time in healthy elderly is associated with chronic low-grade inflammation and advanced glycation end product.
Topics: Aged; Aged, 80 and over; Aging; Arginine; Biomarkers; Electromyography; Female; Glycation End Products, Advanced; Humans; Inflammation; Isometric Contraction; Linear Models; Lysine; Male; Muscle Weakness; Muscle, Skeletal; Reaction Time; Sarcopenia; Sex Factors | 2018 |
Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women.
Topics: Aged; Aged, 80 and over; Aging; Disability Evaluation; Female; Glycation End Products, Advanced; Humans; Lysine; Muscle Strength; Muscle Weakness; Prognosis; Women's Health | 2009 |
Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4.
Topics: Adult; Australia; Charcot-Marie-Tooth Disease; Child; Child, Preschool; Exons; Family Health; Female; Flavoproteins; Foot Deformities; Genotype; Glutamic Acid; Humans; Lysine; Male; Middle Aged; Models, Molecular; Muscle Weakness; Mutation; Neural Conduction; Phenotype; Phosphoric Monoester Hydrolases; Sural Nerve | 2011 |
The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Axons; Charcot-Marie-Tooth Disease; Deafness; DNA Mutational Analysis; Female; Genetic Testing; Glutamic Acid; Humans; Lysine; Male; Microscopy, Electron; Middle Aged; Muscle Weakness; Mutation; Neural Conduction; Neurofilament Proteins; Pedigree; Peripheral Nerves; Phenotype; Protein Structure, Tertiary; Sural Nerve | 2004 |
Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Endothelin-1; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension; Isothiuronium; Kidney; Kidney Function Tests; Lysine; Muscle Weakness; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Nitroarginine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Ventricular Function, Left | 2007 |